-
ICD-10-CM Codes
›
-
D50-D89
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
›
-
D60-D64
Aplastic and other anemias and other bone marrow failure syndromes
›
-
D63-
Anemia in chronic diseases classified elsewhere
›
-
2022 ICD-10-CM Diagnosis Code D63.0
2022 ICD-10-CM Diagnosis Code D63.0
Anemia in neoplastic disease
2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code Manifestation Code
- D63.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2022 edition of ICD-10-CM D63.0 became effective on October 1, 2021.
- This is the American ICD-10-CM version of D63.0 - other international versions of ICD-10 D63.0 may differ.
ICD-10-CM Coding Rules
- D63.0 describes the manifestation of an underlying disease, not the disease itself.
Code FirstCode First Help
Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.
- neoplasm (C00-D49
ICD-10-CM Range C00-D49
Neoplasms- C00-C14 Malignant neoplasms of lip, oral cavity ...
- C15-C26 Malignant neoplasms of digestive organs
- C30-C39 Malignant neoplasms of respiratory and i...
- C40-C41 Malignant neoplasms of bone and articula...
- C43-C44 Melanoma and other malignant neoplasms o...
- C45-C49 Malignant neoplasms of mesothelial and s...
- C50-C50 Malignant neoplasms of breast
- C51-C58 Malignant neoplasms of female genital or...
- C60-C63 Malignant neoplasms of male genital orga...
- C64-C68 Malignant neoplasms of urinary tract
- C69-C72 Malignant neoplasms of eye, brain and ot...
- C73-C75 Malignant neoplasms of thyroid and other...
- C76-C80 Malignant neoplasms of ill-defined, othe...
- C7A-C7A Malignant neuroendocrine tumors
- C7B-C7B Secondary neuroendocrine tumors
- C81-C96 Malignant neoplasms of lymphoid, hematop...
- D00-D09 In situ neoplasms
- D10-D36 Benign neoplasms, except benign neuroend...
- D37-D48 Neoplasms of uncertain behavior, polycyt...
- D3A-D3A Benign neuroendocrine tumors
- D49-D49 Neoplasms of unspecified behavior
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D63.0. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
Type 2 ExcludesType 2 Excludes Help
A type 2 excludes note represents "not included here". A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code (D63.0) and the excluded code together.
The following code(s) above
D63.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D63.0:
- Anemia, neoplastic
- Hemolytic anemia due to nonlymphoid neoplasm
- Hemolytic anemia, nonlymphoid neoplasm
ICD-10-CM D63.0 is grouped within Diagnostic Related Group(s) (MS-DRG v39.0):
- 811 Red blood cell disorders with mcc
- 812 Red blood cell disorders without mcc
Convert D63.0 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
Code annotations containing back-references to D63.0:
- Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) D64.9
ICD-10-CM Diagnosis Code D64.9
Anemia, unspecified
2016 2017 2018 2019 2020 2021 2022 Billable/Specific Code
- in (due to) (with)
- neoplastic disease D63.0 - see also Neoplasm
ICD-10-CM Codes Adjacent To D63.0
D61.8 Other specified aplastic anemias and other bone marrow failure syndromes
D61.810 Antineoplastic chemotherapy induced pancytopenia
D61.811 Other drug-induced pancytopenia
D61.89 Other specified aplastic anemias and other bone marrow failure syndromes
D61.9 Aplastic anemia, unspecified
D62 Acute posthemorrhagic anemia
D63 Anemia in chronic diseases classified elsewhere
D63.0
Anemia in neoplastic disease
D63.1 Anemia in chronic kidney disease
D63.8 Anemia in other chronic diseases classified elsewhere
D64.0 Hereditary sideroblastic anemia
D64.1 Secondary sideroblastic anemia due to disease
D64.2 Secondary sideroblastic anemia due to drugs and toxins
D64.3 Other sideroblastic anemias
D64.4 Congenital dyserythropoietic anemia
D64.8 Other specified anemias
D64.81 Anemia due to antineoplastic chemotherapy
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
